Back to Trials
NCT00131014Recruiting

Establishing a Tumor Bank in Families With Multiple Lymphoproliferative Malignancies

Dana-Farber Cancer Institute

Start Date

8/9/2004

Completion Date

1/1/2033

Summary

The purpose of this study is to investigate possible genetic factors that contribute to the development of lymphomas. The databank will be used to determine whether familial lymphomas have unique genetic characteristics different from sporadic lymphomas and to attempt to identify a gene that confers an increased risk of lymphoma.

Detailed Description

* Patients who participate will be asked to complete detailed family and medical history questionnaires initially, with a follow-up questionnaire every year. * Patients will be asked to supply a blood sample and possibly a mouthwash sample, both of which can be done by mail. * Patients will be asked to consent to the release of their lymphoma tissue block for the purposes of the study. * Patients will be given letters of invitation for their affected relatives to invite them to participate.

Eligibility Criteria

Age Range: 18 years to No maximum

Inclusion Criteria: * Any individual diagnosed with non-Hodgkin's lymphoma or Hodgkin's disease or chronic lymphocytic leukemia (CLL), who has a 1st degree relative (parent, sibling or child) with a lymphoproliferative disorder; or families in which the individual has a lymphoproliferative disorder, and an unusual clustering of frequent or premature solid tumors is also observed. * Family members of the individual, either affected or unaffected with lymphoma, who are contacted by the individual and agree to participate in the study. * Deceased family members may be included in the study. Public records such as death certificates may be used to confirm the history. Consent for medical records or tissue blocks will be obtained from the deceased family member's next of kin. The hierarchy of relatives defined as next of kin is spouse, offspring, parents and siblings. Archived tissue samples may be used for genetic research. * Age \> 18 years Exclusion Criteria: * Subjects without a family history of lymphoma

Interested in This Trial?

Contact the trial locations directly using the information below to learn more about enrollment.

Expressing interest lets you review the study and consent before we connect you with the research site.

Conditions

Non-Hodgkin's LymphomaHodgkin's DiseaseLeukemia, Lymphocytic, ChronicLymphoproliferative Disorders

Locations

Dana-Farber Cancer Institute

Boston, Massachusetts 02115

United States